Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 701–800 of 860
Wang, J.-R., Jurado-Aguilar, J., Barroso, E., Rodríguez‐Calvo, R., Camins, A., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01972-5 · Cited by 5
Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS)
Chameroy, K. A. (2010) · Cited by 6
Nuclear Receptors in Energy Metabolism
Walth-Hummel, A. A., Herzig, S., & Rohm, M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_4 · Cited by 5
Arias-Amézquita, F., Otero, J. M., Londoño, E., Becerra, H., Carvajalino, S., Rodríguez, C. I., Granados, J., Quintero, P., Mora, M., Castro, C., et al. (2012) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2012.03.001 · Cited by 4
Kudinov, V. A., Zakharova, T. S., Torkhovskaya, T. I., Ipatova, O. M., & Archakov, A. I. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818020075 · Cited by 3
Martin, W. P., Chuah, Y. H. D., Conroy, E., Reynolds, A., Judge, C. S., López-Hernández, F. J., le Roux, C. W., & Docherty, N. G. (2021) · BMJ Open Science · doi:10.1136/bmjos-2021-100240 · Cited by 2
Chapter 1 Regulation of Metabolism by Nuclear Hormone Receptors
Huang, H.-J., & Schulman, I. G. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87001-4 · Cited by 4
Tachibana, K. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.1223 · Cited by 3
Self-citationLigands to peroxisome proliferator-activated receptors as therapeutic options for metabolic syndrome
Liu, Y., & Miller, A. R. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.015 · Cited by 3
Lahiri, S., & Wahli, W. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.076 · Cited by 4
Rathinasabapathy, A., Sayyed, S. G., Doshi, L. S., Dixit, P., Chandak, P. G., Dixit, A. V., Brahma, M. K., Deshmukh, N., Gupte, R. D., Damre, A. A., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.036 · Cited by 3
Yu, X., Su, B. L., Wang, X., Feng, H. J., & Jin, C. (2014) · Genetics and Molecular Research · doi:10.4238/2014.july.7.1 · Cited by 3
PPAR: A Pivotal Regulator in Metabolic Syndromes
Fei, J. (2012) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e113 · Cited by 3
Mitochondrial Function in Diabetes: Pathophysiology and Nutritional Therapeutics
Mechanick, J. I. (2006) · Nutrition and disease prevention · doi:10.1201/9781420014884.ch13 · Cited by 3
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_14 · Cited by 4
Stefanski, A., & Majkowska, L. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.12.1713 · Cited by 3
Kasuga, J.-I., Oyama, T., Nakagome, I., Aoyama, A., Sako, K., Makishima, M., Hirono, S., Morikawa, K., Hashimoto, Y., & Miyachi, H. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.709 · Cited by 3
Miyachi, H. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.803 · Cited by 3
Rôles de PPARδ dans la physiologie du muscle squelettique
Grimaldi, P. A. (2005) · médecine/sciences · doi:10.1051/medsci/2005213239 · Cited by 4
Kennedy, S. R. (2007) · Stirling Online Research Repository (University of Stirling) · Cited by 5
Zhu, W., Chang, W., Chen, T., Li, M., Han, Z., Sun, N., Fang, W. Y., & Wang, D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120571 · Cited by 7
Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity
Siqueira, J. S., Castelli, S., Palacio, T. L. N., Aiello, G., Baldelli, S., D’Amato, A., Bruno, A. D., Lombardo, M., & Tripodi, G. (2025) · Nutrients · doi:10.3390/nu18010080 · Cited by 4
Pinnelli, V. B. K., Surendra Babu, T., Jayashankar, C. A., Bhanu, P., Murthuza, A. A., Madhu, M. T., Srilekha, N., Sam, K. T., Hussain, M. H., Akshay, A. S., et al. (2026) · Cureus · doi:10.7759/cureus.104583 · Cited by 3
Zhang, Y., Liu, C., Ju, H., Jia, R., Gao, S., Liu, X., Menéndez‐Arias, L., & Zhan, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18611-0.00028-0 · Cited by 3
PPAR/PGC-1 Regulation of Metabolism in Cardiac Disease
Duncan, J. G., & Finck, B. N. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_4 · Cited by 2
PPARs. Receptores activados por proliferadores peroxisomales
Zelechower, H., & Elbert, A. E. (2009) · Revista De Nefrologia Dialisis Y Trasplante · Cited by 2
Li, Y., & Sun, G. (2015) · Functional & Integrative Genomics · doi:10.1007/s10142-015-0469-5 · Cited by 2
Tissue Distribution and Versatile Functions of PPARs
Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_5 · Cited by 5
Tung, Y., Lyu, K.-N., Chen, Y.-C., & Chien, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.010 · Cited by 3
Sugita, K., Hashimoto, Y., Motoshima, K., Noguchi‐Yachide, T., & Ishikawa, M. (2010) · Heterocycles · doi:10.3987/rev-10-sr(e)7 · Cited by 2
The Liver in Metabolic Syndrome
D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 3
Data storage: bringing us a step closer to data sharing?
Rocca‐Serra, P., & Elliott, R. M. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061747 · Cited by 2
Vil trening in vivo prege skjelettmuskelceller in vitro
Lund, J. (2013) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Xiang, L., Shi, J., Zhu, Z., Ru, Y., Peng, L., Wang, W., Zhao, H., Liu, R., Pu, Y., He, L., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110910 · Cited by 1
Nuclear‐Mitochondria Crosstalk in Senescent Adipose‐Derived Stem Cells
Zhang, Y., Du, Y., Ling, S., Wang, H., He, J., Li, J., Huo, K., Liu, B., Li, Q., Wei, J., et al. (2026) · Smart Medicine · doi:10.1002/smmd.70043 · Cited by 1
Evaluation of Mitochondrial Functions and Dysfunctions in Muscle Biopsy Samples
Capel, F., Barquissau, V., Richard, R., & Morio, B. (2012) · InTech eBooks · doi:10.5772/30705 · Cited by 1
Peroxisome Proliferator Activated Receptor-δ (PPAR-δ)
Choi, K. M. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.4.297 · Cited by 2
Muscle-Specific PPAR β/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
Erol, A. (2007) · PPAR Research · doi:10.1155/2007/30578 · Cited by 3
Peroxisome proliferator‐activated receptor‐δ as emerging target in liver disease
Schnabl, B. (2009) · Drug Development Research · doi:10.1002/ddr.20358 · Cited by 1
The Role of PPARδ on Mitochondrial Biogenesis of Mouse Skeletal Muscle
고진호, Ryun, J. S., Kim, K., & 김상현 (2014) · Exercise Science · doi:10.15857/ksep.2014.23.4.315 · Cited by 1
Turek, J. J. (2006) · CRC series in modern nutrition science · doi:10.1201/9780203500231.ch3 · Cited by 3
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00020-2 · Cited by 2
Fat Feeding and Muscle Fat Deposition Eliciting Insulin Resistance
Kraegen, E. W., Cooney, G. J., Ye, J. M., & Furler, S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_16 · Cited by 1
Genetik der Leistungsfähigkeit und Trainierbarkeit
Blume, K., Pitsiladis, Y. P., Wang, G., & Wolfarth, B. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1591-6_17 · Cited by 4
Kudinov, V. A., Zakharova, T. S., Torkhovskaya, T. I., Ipatova, O. M., & Archakov, A. I. (2018) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20186401066 · Cited by 1
Lorentzen, K. (2013) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Yahia, R. B., Lichnovská, R., & Brychta, T. (2005) · Biomedical Papers · doi:10.5507/bp.2005.032 · Cited by 1
Aljawadi, A. (2013) · ThinkTech (Texas Tech University) · Cited by 1
The role of S6K1 in development and maintenance of nutrient homeostasis
Um, S. H. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003445956 · Cited by 1
Munyemera, I. (2014) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Recent Developments in the Treatment of Diabetes Type 2
Nehlin, J. O. (2007) · Springer eBooks · doi:10.1007/1-4020-5058-5_8 · Cited by 1
Røst, T. H. (2008) · NVA (Nasjonalt vitenarkiv)
Serra, L. S. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Transgenic Animal Models and the Metabolic Syndrome
Franckhauser, S., & Bosch, F. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50004-8
Barroso, E., Serrano-Marco, L., Salvad, L., Palomer, X., & Vzquez-Carrer, M. (2012) · InTech eBooks · doi:10.5772/27647
The Effects of a High Fat Diet on Mitochondrial Biogenesis and Inflammation in the Brain
Vervaecke, L. S., Davis, J. M., Carson, J., Murphy, A., & Thompson, R. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000495380.12776.95
Skeletal Muscle and Mitochondrial Toxicity
Johnson, T. E. (2008) · Wiley eBooks · doi:10.1002/9780470372531.ch7
Skeletal muscle metabolic flexibility : The roles of AMP-activated protein kinase and calcineurin
Long, Y. C. (2007) · Figshare
SUMO-1 conjugation in normal and stress conditions in vivo
Mikkonen, L. (2013) · Helda - University of Helsinki Institutional Repository
Resistencia a insulina en el músculo esquelético: conexión con la obesidad
Vázquez, I. N., Fernández‐Veledo, S., García‐Guerra, L., Vila‐Bedmar, R., & Lorenzo, M. (2008) · Anales de la Real Academia Nacional de Farmacia
A molecular basis for the loss of muscle oxidative phenotype: Implications for COPD
Remels, A. H. V. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091211ar
Chapter 3 PPARδ: Emerging therapeutic potential of novel agonists in lipid and glucose homeostasis
Dressel, U., & Muscat, G. E. O. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05003-4
PPAR‐Based Therapies for the Management of Atherosclerosis
Gizard, F., & Pineda‐Torra, I. (2010) · Wiley eBooks · doi:10.1002/9783527629589.ch6
Modulation of VLDL triglyceride metabolism
Bijland, S. (2010) · Leiden Repository (Leiden University)
Oh, Y.-J., Shin, S.-S., Yoon, M., & Kim, B. (2009) · Journal of Oriental Neuropsychiatry
Bioinformatics Software and Methods for Genome-wide Association and ChIP-Seq Studies.
Welch, R. (2013) · Deep Blue (University of Michigan)
Fat in hearts: Uptake, storage, and turnover
Trent, C. M. (2014) · doi:10.7916/d8c53j0x
PPAR β/δ, inflamació i resistència a la insulina en adipòcits
Marco, L. S. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The effect of PPARδ agonists (HS00098) on serum lipid profiles in diet-induced obese rhesus monkeys
Luo, Q., Zeng, W., Chen, Z., Cheng, A., Wang, M., Shen, Y., Zhu, C.-M., & Bi, F.-J. (2012) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2012.58056
Comparison among GGEx16, GGEx18 and gambitongseong-capsule for anti-obesity gene activity
Oh, J.-H., Ahn, Y. J., Lee, H. R., Lim, H., Lee, H., Yoon, M., & Shin, S. S. (2013) · The Korea Journal of Herbology · doi:10.6116/kjh.2013.28.2.39
Gregoire, F. M. (2008) · PPAR Research · doi:10.1155/2008/736362
Lorenzo, M. (2009) · Dialnet (Universidad de la Rioja) · Cited by 4
Estudo do controle traducional de PPAR durante o processo de diferenciação de macrófagos
Cambiaghi, T. D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-25032010-145009 · Cited by 2
Caracterització del gen Acetoacetil-CoA sintetasa
de Farmàcia, F., & de Bioquímica, D. (2008)
ResearchC, a resveratrol tetramer, activates PPARα and PPARβ/δ in vitro and in vivo
Tsukamoto, T., Nakata, R., Tamura, E., Kosuge, Y., Kariya, A., Katsukawa, M., Mishima, S., Ito, T., Iinuma, M., Akao, Y., et al. (2010)
Pereyra, A. S. (2015) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/50513
Resveratrol as a Novel Therapeutic Agent for Treating Duchenne Muscular Dystrophy
Burt, M. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3321
Nutrient regulation of energy metabolism in relation to obesity and type 2 diabetes
Wensaas, A. J. (2010) · NVA (Nasjonalt vitenarkiv)
Boucher, P., & Vogel, H. G. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_53-1
The role of C. elegans NHR-49 in regulating global lipid homeostasis
Pathare, P. (2011) · authors@Fred Hutch (Fred Hutchinson Cancer Research Center)
Greene, N. P. (2011) · OakTrust (Texas A&M University Libraries)
CONTROL TRANSCRIPCIONAL I AL·LOSTÈRIC DEL GEN CARNITINA PALMITOÏLTRANSFERASA 1B (CPT1B)
de Farmàcia, F., de Bioquímica, D., & Molecular, I. B. (2006)
ReviewArticle The Role of PPARs in Cancer
Tachibana, K., Yamasaki, D., Ishimoto, K., & Doi, T. (2008)
Self-citationErbe, D. V., & Tobin, J. F. (2008)
Inoue, T., Kohro, T., Tanaka, T., Kanki, Y., Li, G., Poh, H.-M., Mimura, I., Kobayashi, M., Taguchi, A., Maejima, T., et al. (2014)
Self-citation生活習慣病の治療戦略 4 PPARδとメタボリックシンドローム
Tanaka, T. (2006) · Folia Pharmacologica Japonica · doi:10.1254/fpj.128.225
Self-citationMcFadden, J. W. (2009) · VTechWorks (Virginia Tech) · Cited by 1
Regulation of adult muscle phenotype by PPARδ
Thesis, M., & Lunde, I. G. (2006)
Overview of insulin resistance and the metabolic syndrome
Sattar, N. A., & Mukhopadhyay, B. (2003) · CRC Press eBooks · doi:10.3109/9780203481165-13
Linking nutrition and metabolism, a role for the membrane bile acid receptor TGR5
Thomas, C., Auwerx, J. H., & Schoonjans, K. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9644-0_19
Self-citationPeroxisome proliferator activated receptors and energy metabolism
Gervois, P. P., Fruchart, J., & Staels, B. (2003) · CRC Press eBooks · doi:10.3109/9780203481165-14
Adipose Drug Targets for Obesity Treatment
Giacobino, J., Lehr, L., & Boss, O. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.pt4
Changes of the Musculoskeletal System in the Metabolic Syndrome
Palmaj, J., & Palmajová, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-31169-2_16
Role of Peroxisome Proliferator‐Activated Receptors in Inflammation and Angiogenesis
Acharya, S. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch15
The Role of the Retinoblastoma Protein Family in Skeletal Myogenesis
Ciavarra, G. (2011) · Library and Archives Canada (Government of Canada)
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.